Overview
- 9 inspections across 9 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-18.
At a glance
Inspections
9
Sites
9
Observations
0
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biotechpharma, Biotechnologines Farmacijos Centras UAB | 18 Sep 2025 | Human Drugs | On file |
| Lonza AG | 4 Apr 2025 | Human Drugs | On file |
| Lonza AG | 4 Apr 2025 | Human Drugs | On file |
| BioMarin International Limited | 13 Dec 2024 | Human Drugs | On file |
| Binex Co., Ltd | 20 Jun 2024 | Human Drugs | On file |
Sites inspected
Biotechpharma, Biotechnologines Farmacijos Centras UABVerkiai, Lithuania1 insp.
Lonza AGVisp, Switzerland1 insp.
Lonza AGVisp, Switzerland1 insp.
BioMarin International LimitedRingaskiddy, Ireland1 insp.
Binex Co., LtdYeonsu, Korea (the Republic of)1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen7 shared
Hyung-Yul Lee2 shared
Andrea Franco1 shared
Jennifer E Veenhof1 shared
Della Shin1 shared
Erin A Wall1 shared
Aditi Thakur1 shared
Zhong Li1 shared
Santos E Camara1 shared
Michael A Charles1 shared
Full investigator report
Get the verbatim findings behind Melissa D Ray's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site